Thomas Oxley’s Post

Explore Opportunities in the Dynamic Pacemakers Market! The Pacemakers Market is projected to experience a growth of 3-4% by 2028, fueled by various factors such as the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, technological advancements in pacemaker technology, a growing aging population, and favorable reimbursement environments in key markets. 🌐 Key Market Players: Join industry leaders shaping the future! 🌟 Explore opportunities with companies at the forefront of innovation, including Boston Scientific, Cook Medical, GE HealthCare, ZOLL Medical Corporation, Medtronic, LivaNova, OSYPKA MEDICAL GmbH, BIOTRONIK, Lepu Medical Technology (Beijing) Co., Ltd., and Abbott. 💼 Connect with Our Expert: Looking to dive deeper into the Pacemakers Market or explore collaboration possibilities? Connect with our expert, t, Manoj Sahasrabu he Gunjan Tha ur Gaurav Si ha BA Ram Song ra Minal Ka ra Kalpesh J in MEHER PANJW NI Madhuri, and gain valuable insights. 🤝 #HealthcareInnovation #Pacemakers #CardiovascularHealth #MedicalTechnology #ConnectWithExperts #IndustryInsights #HealthTechRevolution #CardioCare #MedicalInnovation #FutureOfHealthcare #InvasiveProcedures #TechAdvancements #MarketGrowth #HeartHealth #HealthcareTrends #IndustryLeadership #ConnectAndCollaborate #PacemakersInsights #MedTechLeaders #GlobalHealthcare #InnovationHub #HealthcareAnalytics #CardiovascularTech #ExpertConnect #MarketForecast #DigitalHealthWave

First-line aspiration can be the answer to improving access to stroke care beyond specialised centres, according to Vincent Costalat. Marios Psychogios, Prof. Dr. favours highly trackable, durable aspiration catheters that work in combination with all thrombectomy devices. In this interview they outline what matters most in aspiration catheter technology – from #Trackability and #LumenIntegrity to #AspirationForce.  In the end, both professors share the same ‘aspiration’ in managing stroke:  “We want to open vessels!”    #Sponsored by Penumbra, Inc. Watch now: https://lnkd.in/dCUNHRFg

Why Inceptiv™ closed-loop sensing technology? How does it work? How does it help SCS patients? Learn from pain management physicians Drs. Melissa Murphy, MD, MPH and Krishnan Chakravarthy M.D., Ph.D, along with Distinguished Biomedical Engineer at Medtronic, Dave Dinsmoor, P.E., why Inceptiv™ closed-loop SCS system is set to transform SCS therapy. The Inceptiv™ system senses† and responds automatically adjusting stimulation based on their neural responses to maintain consistant therapy during all patient activites. See risk information: https://bit.ly/4bca1CB Sense the future with Inceptiv™ SCS! Go to https://lnkd.in/ezEmPGNc or talk to your Medtronic Representative to learn more about why Inceptiv™ SCS system is the most advanced SCS system with closed-loop technology. †Sensing signals may not be measurable in all cases. #MDTPainInterventions #PatientFirst #InceptivSCS #ClosedLoopTechnology #MedtronicSCS #ClosedLoop #SCS #SpinalCordStimulation #ECAP

Why the Shockwave Deal is Great News for Everyone 🎉 In a remarkable move, healthcare behemoth Johnson & Johnson has committed an additional $13B into their MedTech division, with a primary focus on cardiovascular health. ❤️ The company has inked a significant deal with Shockwave Medical, a specialist in technology designed to unclog arteries. 💉 Founded in 2009, Shockwave Medical has been at the forefront of intravascular lithotripsy technology, utilizing sonic pressure waves to break down calcium lesions in our arteries and restore optimal blood flow. 🔊 This ingenious approach draws parallels with techniques employed to fragment kidney stones. A truly game-changing innovation in the treatment of both coronary artery and peripheral artery disease. 🚑 This strategic acquisition clearly illustrates the attractiveness of the MedTech industry, with multinationals like J&J willing to invest substantial resources. The fact that Shockwave's revenue saw an impressive 49% increase last year to $730 million further underlines the potential of this flourishing sector. 💰 With the increasing investment in MedTech, how do you see this industry evolving in the future? What are the key trends we should look out for? #HealthcareInnovation #MedTech #JohnsonAndJohnson #ShockwaveMedical

📢 News Update: Unlocking relief for chronic pain sufferers with closed-loop technologies in neuromodulation. Last month, Medtronic presented new clinical data at the North American Neuromodulation Society (NANS) Annual Meeting, showing efficacy in patients with chronic low back pain and leg pain. Learn more: https://lnkd.in/gqdSKFTV At Avicenna, we laser ablate various components of a neurostimulation electrode, such as the wire insulation inside the neurostimulation lead. The wire is designed to conduct electrical impulses from a neurostimulator device to the targeted nerves. https://lnkd.in/gY4Tyy7r #Neuromodulation #ChronicPain #PainManagement #MedicalTechnology"

Cerebral Oximetry Monitoring Market Latest trending report is booming globally by Top Leading Players The study encompasses profiles of major Companies/Manufacturers operating in the global Cerebral Oximetry Monitoring Market. Key players profiled in the report include: Boston Consulting Group (BCG) Scientific, Omron Healthcare, Welch Allyn, Honeywell | Life Sciences Sciences, Natus Medical Incorporated Medical, Mindray, Edwards Lifesciences, GE HealthCare, Masimo, Philips, and Medtronic and More... Get PDF Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, List of Tables & Figures, Chart):  https://lnkd.in/dj_SjWuf

EMEA HCPs: What impacts the clinical success of mechanical thrombectomy? It only takes one click to watch the NeuroNews interview where Prof. Costalat and Prof. Psychogios share their experience and aspirations in stroke management.   Rx only. Risk info: peninc.info/risk

Simply the best and smallest/thinnest SCS battery on the market. Inceptiv automatically senses and responds every 20 ms to the patients ECAP’s. That is five times faster than the blink of an eye. 1.5 & 3T compatiable! Patients no longer have to worry about being over/under dosed and receiving suboptimal therapy. In addition, Inceptiv can deliver multiple different HD wave forms that our competion can’t! What is not to like? #mdtemployee #gamechanger #overdrivetechnology

Thrilled to witness the rapid growth of #ArtificialDiscReplacement in the spine #Medtech markets, driven by a rising preference for #MotionPreservation over traditional fusion. Advanced technologies, such as AxioMed, mimicking the natural human disc, will further accelerate demand. Anticipating sustained long-term market expansion ahead. #MedTech #SpineInnovation #ArtificialDiscReplacement #MotionPreservation #InnovationLeadership KICVentures

Automatic, objective, daily remote monitoring powers BIOTRONIK Neuro’s one-of-a-kind proactive care. What does that mean for SCS patients? Join us at #ASPN2024 for “Unparalleled Proactive Care: Clinical Evidence for Prospera™”. At this lunch symposium, we’ll explore the data driving BIOTRONIK Neuro’s spinal cord stimulation (SCS) innovation—the Prospera SCS System with Embrace One™. Register today: https://ow.ly/aGW450SpvBr #BIOTRONIKNeuro